Cumberland Pharmaceuticals Files 2024 10-K
Ticker: CPIX · Form: 10-K · Filed: Mar 7, 2025 · CIK: 1087294
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
CPix filed its 2024 10-K. Full year financials and biz details out.
AI Summary
Cumberland Pharmaceuticals Inc. filed its 2024 10-K on March 7, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Nashville, TN, operates in the pharmaceutical preparations sector. Key financial details and business operations for the fiscal year are outlined in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Cumberland Pharmaceuticals' financial performance and business activities for the fiscal year 2024, including risks and strategic information.
Risk Assessment
Risk Level: low — The filing is a standard annual report (10-K) and does not indicate any immediate or unusual risks.
Key Players & Entities
- CUMBERLAND PHARMACEUTICALS INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-07 (date) — Filing Date
- Nashville, TN (location) — Company Address
FAQ
What is Cumberland Pharmaceuticals Inc.'s primary industry classification?
Cumberland Pharmaceuticals Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When was the 10-K filing for the fiscal year ending December 31, 2024, submitted?
The 10-K filing was submitted on March 7, 2025.
What is the company's business address?
The company's business address is 2525 WEST END AVENUE, SUITE 950, NASHVILLE, TN 37203.
Is Cumberland Pharmaceuticals Inc. considered an accelerated filer?
No, Cumberland Pharmaceuticals Inc. is listed as a 'Non-accelerated Filer'.
What SEC Act does this filing fall under?
This filing falls under the '1934 Act'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 7, 2025 regarding CUMBERLAND PHARMACEUTICALS INC (CPIX).